Clinical Trial Update: Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating sitagliptin after islet autotransplant to improve outcomes in pancreatitis-related diabetes has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Pancreatitis

Drugs mentioned

• Januvia (sitagliptin)

Snippet

Sponsor: University of Minnesota | Conditions: Pancreatitis, Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2016-12-28